RED BANK, N.J. -- Ansell Healthcare Products Inc., a global leader in healthcare barrier protective products, has been awarded two three-year glove contracts by Amerinet, Inc., a St. Louis based healthcare group purchasing organization (GPO). The multi-source surgical agreement and the dual-source examination agreement call for Ansell to provide its full line of latex and latex-free surgical and examination gloves to Amerinet's 20,000-plus members.
The contracts deliver significant savings and renew existing agreements to maintain a long-standing relationship between Amerinet and Ansell. Ansell's status as a preferred glove supplier for Amerinet members caused the GPO to select Ansell, even as it reconfigured its examination gloves portfolio from multi-source to dual-source.
"We look forward to continuing and expanding our relationship with Amerinet," said Harry Bontrager, Ansell's manager of national accounts. "By choosing Ansell to be one of a select few glove manufacturers to contract with, they are validating the quality of product and service we continuously strive to provide."
As part of the agreement, Amerinet members will have access to all Ansell educational programs.
With operations in the Americas, Europe and Asia, Ansell employs more than 12,000 people worldwide and holds leading positions in the natural latex and synthetic polymer glove and condom markets. Ansell operates in three main business segments: Occupational Healthcare, supplying hand protection to the industrial market; Professional Healthcare, supplying surgical and examination gloves to healthcare professionals; and Consumer Healthcare, supplying sexual health products and consumer hand protection.
Amerinet is one of the most innovative and effective healthcare group purchasing organizations in the United States, leading the industry in flexibility with Amerinet's commitment to providing supplier choice for its members.
Source: Ansell
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.
The Neglected Tropical Diseases You’ve Never Heard Of
February 27th 2024The 20 conditions, known as neglected tropical diseases (NTDs), are estimated to affect more than 1 billion people, yet many individuals have never heard of them. Heather Saunders, MPH, RN, CIC, discusses 5 of them and what is being done to prevent their spread.